Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.40519 | 70 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.13035 | 68 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.26282 | 69 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.08892 | 67 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.15546 | 68 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.46797 | 71 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.60711 | 73 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.25296 | 69 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.18912 | 68 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.26542 | 69 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.26355 | 69 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.15724 | 68 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.32825 | 70 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.29181 | 69 |